CD47 is crucially linked with hematologic malignancies, such as non-Hodgkin lymphoma (NHL), acute myeloid leukemia (AML), lymphoblastic lymphoma/acute lymphoblastic leukemia (LBL/ALL), and multiple myeloma (MM) (36, 37). Here, CD47 is linked to hematologic disorder.